Company Profile

ANUH PHARMA LTD.

NSE : NABSE : 506260ISIN CODE : INE489G01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE143.603.4 (+2.43 % )
PREV CLOSE (Rs.) 140.20
OPEN PRICE (Rs.) 142.00
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 45151
TODAY'S LOW / HIGH (Rs.)139.00 144.00
52 WK LOW / HIGH (Rs.) 48.7 218.7
NSE
This Company is not listed in NSE

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.00
Dividend Yield(%) 0.96
TTM EPS (Rs.) 5.74
P/E Ratio 25.00
Book Value (Rs.) 37.02
Face Value (Rs.) 5
MCap (Rs. in Mn) 7196.08
Price/Earning (TTM) 17.41
Price/Sales (TTM) 1.87
Price/Book (MRQ) 3.88
PAT Margin (%) 4.50
ROCE (%) 10.87
Incorporation Year : 1960

Management Info :

Jasvantlal G Shah - Chairman Bipin Shah - Managing Director

Registered Office :

Address : 3 - A, Shivsasgar Estate, North Wing,Dr. Annie Basant Road,Worli,
Mumbai,
Maharashtra-400018

Phone : +91-22-66227575

Email : anuh@sk1932.com

Website : www.anuhpharma.com

Registrar's Details : Bigshare Services Pvt Ltd
Bharat Tin Works Building,1st floor, Opp. Vasant Oasis,Andheri (E),Mumbai
Listing : BSE
NEWS More
09Nov11-09-2020$New Listing New Listing
inter alia, 1.The proposal for listing of Equity Shares of the Company on National Stock Exchange of India Limited (NSE) subject to meeting of the criteria of NSE Listing.
inter alia, 1.The proposal for listing of Equity Shares of the..
30Sep09-30-2020$Anuh Pharma jumps on getting approval for Pyrimcthamine API Anuh Pharma jumps on getting

Anuh Pharma is currently trading at Rs. 194.50, up by 4.60 points or 2.42% from its previous closing of Rs. 189.90 on the BSE.

The scrip opened at Rs. 194.45 and has touched a high and low of Rs. 195.30 and Rs. 186.00 respectively. So far 22586 shares were traded on the counter.

The BSE group 'X' stock of face value Rs. 5 has touched a 52 week high of Rs. 218.70 on 25-Aug-2020 and a 52 week low of Rs. 48.70 on 24-Mar-2020.

Last one week high and low of the scrip stood at Rs. 207.80 and Rs. 182.00 respectively. The current market cap of the company is Rs. 967.66 crore.

The promoters holding in the company stood at 72.09%, while Non-Institutions held 27.90% stake in the company.

Anuh Pharma has received approval from World Health Organization (WHO) - Geneva Prequalification for Pyrimcthamine API which is used as Anti - Malarial Durgs.

Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) and a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

Anuh Pharma is currently trading at Rs. 194.50, up by 4.60 poin..
29Sep09-29-2020$Anuh Pharma gets approval for Pyrimcthamine API Anuh Pharma gets approval fo

Anuh Pharma has received approval from World Health Organization (WHO) - Geneva Prequalification for Pyrimcthamine API which is used as Anti - Malarial Durgs.

Anuh Pharma is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs) and a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

Anuh Pharma has received approval from World Health Organizatio..
29Jul07-29-2020$Anuh Pharma informs about board meeting Anuh Pharma informs about bo

Pursuant to the provisions of Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Anuh Pharma has informed that the Meeting of the Board of Directors of the Company is scheduled to be held on Friday, 7th August, 2020, to consider and approve Unaudited Financial Results of the Company for the quarter ended 30th June, 2020, to consider the proposal of Bonus Issue of Equity Shares, to fix the record date and to consider any other matter with the permission of the Chairman. Further, pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and in compliance with the Company's Code of Conduct for prevention of Insider Trading, the Trading window for dealing in the securities of the Company has been closed for the Designated Persons and their immediate relatives, from Wednesday, 1st July, 2020 till 48 hours after the declaration of Unaudited Financial Results of the Company for the quarter ended June 30, 2020 up to Sunday, 9th August, 2020.

The above information is a part of company’s filings submitted to BSE.

Pursuant to the provisions of Regulation 29(1) of the SEBI (Lis..
04May05-04-2020$Anuh Pharma informs about compliance certificate Anuh Pharma informs about co

Pursuant to the provisions of Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 [SEBI (LODR), 2015], Anuh Pharma has informed that it has enclosed the Compliance Certificate for the half year ended on March 31, 2020 jointly signed by authorised representative of Bigshare Services, Registrar and Share Transfer Agent of the Company certifying compliance with the requirements of Regulation 7(2) of the SEBI (LODR), 2015.

The above information is a part of company’s filings submitted to BSE.

Pursuant to the provisions of Regulation 7(3) of the SEBI (List..
Financials More
Rs. in Millions
QTR Sep 20 ANNUAL 20
Net Profit66.3699999999999143.05
Gross Profit 98.8899999999999 191.55
Operating Profit 140.96269.8
Net Sales 1122.353069.6
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Procter&Gamble Healt (BSE)
 6878.70 (8.26%)
M.Cap ( in Cr)
11418.22
Divis Lab (BSE)
 3607.60 (1.76%)
M.Cap ( in Cr)
95770.44
Ipca Laboratories (BSE)
 2196.85 (2.86%)
M.Cap ( in Cr)
27867.51
JB Chem & Pharma (BSE)
 994.25 (4.41%)
M.Cap ( in Cr)
7683.77
IOL Chem & Pharma (BSE)
 780.65 (5.02%)
M.Cap ( in Cr)
4582.85
Shareholding Pattern More
PROMOTERS 71.19 %
NON-INSTITUTION 28.81 %
FI/BANKS/INSURANCE 0 %
MUTUAL FUNDS/UTI 0 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
Scheme NameHold(%)
Nippon India Pharma Fun...2.44
F & O Quotes